$42.65
0.631.50%
At Close: -
$42.65
00.00%
After Hours: 4:00 PM EDT
15 minutes delayed
Agios Pharmaceuticals
AGIONASDAQ
Agios Pharmaceuticals (NASDAQ:AGIO) Stock, Insider Trading Activity
Agios Pharmaceuticals: Insider buying and selling updated today.
Institutional Shares Held
34.033M
Institutional Percentage Held
59.9%
| Jul 03, 2024 | Sarah Gheuens | CHIEF MEDICAL OFFICER | 4.67K | $43.85 | -$162.46K | SELL-OPTIONS | 11.95% | 43.736K | Jul 01 | View |
| Jun 07, 2024 | Brian Goff | CHIEF EXECUTIVE OFFICER | 13.412K | $48.84 | -$591.70K | SELL-OPTIONS | 24.94% | 67.192K | Jun 05 | View |
| Jun 05, 2024 | Theodore James Jr Washburn | PRINCIPAL ACCOUNTING OFFICER | -1.362K | $44.39 | -$60.46K | SELL | -47.19% | 1.524K | Jun 03 | View |
| Apr 10, 2024 | Jacqualyn Fouse | DIRECTOR | 8.143K | $27.55 | -$214.64K | SELL-OPTIONS | 6.30% | 137.396K | Apr 08 - Apr 10 | View |
| Mar 11, 2024 | Kaye FosterCheek | DIRECTOR | -1.285K | $31.62 | -$40.63K | SELL | -14.26% | 7.724K | Mar 07 | View |
| Mar 07, 2024 | Kaye FosterCheek | DIRECTOR | -4.715K | $32.00 | -$150.90K | SELL | -34.36% | 9.009K | Mar 05 - Mar 06 | View |
| Mar 07, 2024 | Theodore James Jr Washburn | PRINCIPAL ACCOUNTING OFFICER | -1.913K | $31.75 | -$60.74K | SELL | -39.86% | 2.886K | Mar 05 | View |
| Mar 05, 2024 | Sarah Gheuens | CHIEF MEDICAL OFFICER | 5.192K | $32.57 | -$86.05K | SELL-OPTIONS | 15.33% | 39.066K | Mar 01 - Mar 05 | View |
| Mar 05, 2024 | Cecilia Jones | CHIEF FINANCIAL OFFICER | 1.328K | $32.57 | -$21.89K | SELL-OPTIONS | 9.83% | 14.84K | Mar 01 - Mar 05 | View |
| Mar 05, 2024 | Theodore James Jr Washburn | PRINCIPAL ACCOUNTING OFFICER | 1.913K | $32.57 | -$39.54K | SELL-OPTIONS | 66.29% | 4.799K | Mar 01 - Mar 05 | View |
| Mar 05, 2024 | Brian Goff | CHIEF EXECUTIVE OFFICER | 4.344K | $32.57 | -$135.36K | SELL-OPTIONS | 8.79% | 53.78K | Mar 01 - Mar 05 | View |
| Mar 05, 2024 | James Burns | CHIEF LEGAL OFFICER | 5.192K | $32.57 | -$86.05K | SELL-OPTIONS | 16.24% | 37.169K | Mar 01 - Mar 05 | View |
| Feb 29, 2024 | David Schenkein | DIRECTOR | 0 | $33.15 | -$210.02K | SELL-OPTIONS | 0.00% | 201.936K | Feb 27 | View |
| Feb 27, 2024 | David Schenkein | DIRECTOR | 0 | $32.37 | -$98.94K | SELL-OPTIONS | 0.00% | 201.936K | Feb 23 - Feb 26 | View |
| Feb 22, 2024 | Theodore James Jr Washburn | PRINCIPAL ACCOUNTING OFFICER | -504 | $26.63 | -$13.42K | SELL | -15.53% | 2.741K | Feb 20 | View |
| Feb 14, 2024 | Sarah Gheuens | CHIEF MEDICAL OFFICER | 1.52K | $25.14 | -$16.14K | SELL-OPTIONS | 4.76% | 33.431K | Feb 12 - Feb 14 | View |
| Feb 14, 2024 | James Burns | CHIEF LEGAL OFFICER | 1.288K | $25.14 | -$13.70K | SELL-OPTIONS | 4.24% | 31.666K | Feb 12 - Feb 14 | View |
| Feb 14, 2024 | Theodore James Jr Washburn | PRINCIPAL ACCOUNTING OFFICER | 504 | $25.14 | -$6.86K | SELL-OPTIONS | 18.39% | 3.245K | Feb 12 - Feb 14 | View |
| Jan 24, 2024 | James Burns | CHIEF LEGAL OFFICER | 4.042K | $21.64 | -$36.96K | SELL-OPTIONS | 15.35% | 30.378K | Jan 20 - Jan 24 | View |
| Jan 24, 2024 | Sarah Gheuens | CHIEF MEDICAL OFFICER | 4.042K | $21.64 | -$36.96K | SELL-OPTIONS | 14.50% | 31.911K | Jan 20 - Jan 24 | View |
| Jan 24, 2024 | Cecilia Jones | CHIEF FINANCIAL OFFICER | 3.494K | $21.64 | -$40.81K | SELL-OPTIONS | 36.49% | 13.069K | Jan 20 - Jan 24 | View |
| Jan 24, 2024 | Jacqualyn Fouse | DIRECTOR | 13.178K | $21.64 | -$232.02K | SELL-OPTIONS | 11.35% | 129.253K | Jan 20 - Jan 24 | View |
| Jan 24, 2024 | Brian Goff | CHIEF EXECUTIVE OFFICER | 9.383K | $21.64 | -$165.22K | SELL-OPTIONS | 23.43% | 49.436K | Jan 20 - Jan 24 | View |
| Jan 24, 2024 | Tsveta Milanova | CHIEF COMMERCIAL OFFICER | 3.83K | $21.64 | -$35.01K | SELL-OPTIONS | 40.73% | 13.234K | Jan 20 - Jan 24 | View |
| Jan 09, 2024 | Brian Goff | CHIEF EXECUTIVE OFFICER | 13.461K | $22.99 | -$277.40K | SELL-OPTIONS | 50.62% | 40.053K | Jan 05 - Jan 09 | View |
| Jan 09, 2024 | Jacqualyn Fouse | DIRECTOR | 9.109K | $22.99 | -$192.91K | SELL-OPTIONS | 8.52% | 116.075K | Jan 05 - Jan 09 | View |
| Jan 09, 2024 | James Burns | CHIEF LEGAL OFFICER | 2.087K | $22.99 | -$26.74K | SELL-OPTIONS | 8.61% | 26.336K | Jan 05 - Jan 09 | View |
| Jan 09, 2024 | Sarah Gheuens | CHIEF MEDICAL OFFICER | 3.211K | $22.99 | -$41.13K | SELL-OPTIONS | 13.02% | 27.869K | Jan 05 - Jan 09 | View |
| Jan 05, 2024 | Tsveta Milanova | CHIEF COMMERCIAL OFFICER | 5.573K | $22.32 | -$64.77K | SELL-OPTIONS | 145.47% | 9.404K | Jan 03 - Jan 05 | View |
| Sep 28, 2023 | Cecilia Jones | CHIEF FINANCIAL OFFICER | 5.293K | $24.79 | -$54.02K | SELL-OPTIONS | 123.61% | 9.575K | Sep 26 - Sep 28 | View |
| Aug 21, 2023 | James Burns | CHIEF LEGAL OFFICER | -6.395K | $26.28 | -$168.06K | SELL | -21.12% | 23.89K | Aug 17 | View |
| Aug 11, 2023 | Kaye FosterCheek | DIRECTOR | 0 | $22.02 | -$196.64K | SELL-OPTIONS | 0.00% | 13.724K | Aug 09 | View |
| Aug 10, 2023 | Brian Goff | CHIEF EXECUTIVE OFFICER | 12.513K | $25.48 | -$259.34K | SELL-OPTIONS | 88.88% | 26.592K | Aug 08 | View |
| Aug 09, 2023 | Theodore James Jr Washburn | PRINCIPAL ACCOUNTING OFFICER | -2.918K | $25.39 | -$74.10K | SELL | -51.56% | 2.741K | Aug 07 | View |
| Aug 02, 2023 | Theodore James Jr Washburn | PRINCIPAL ACCOUNTING OFFICER | 2.918K | $26.26 | -$32.35K | SELL-OPTIONS | 106.46% | 5.659K | Aug 01 | View |
| Jun 30, 2023 | James Burns | CHIEF LEGAL OFFICER | 4.043K | $28.36 | -$48.41K | SELL-OPTIONS | 15.41% | 30.285K | Jun 28 - Jun 30 | View |
| Jun 30, 2023 | Jacqualyn Fouse | DIRECTOR | 13.182K | $28.36 | -$303.96K | SELL-OPTIONS | 14.06% | 106.966K | Jun 28 - Jun 30 | View |
| Jun 30, 2023 | Sarah Gheuens | CHIEF MEDICAL OFFICER | 4.043K | $28.36 | -$48.41K | SELL-OPTIONS | 20.10% | 24.159K | Jun 28 - Jun 30 | View |
| Jun 30, 2023 | Brian Goff | CHIEF EXECUTIVE OFFICER | 14.079K | $28.36 | -$324.69K | SELL-OPTIONS | ∞ | 14.079K | Jun 28 - Jun 30 | View |
| Jun 30, 2023 | Cecilia Jones | CHIEF FINANCIAL OFFICER | 3.783K | $28.36 | -$45.29K | SELL-OPTIONS | ∞ | 3.783K | Jun 28 - Jun 30 | View |
| Jun 30, 2023 | Tsveta Milanova | CHIEF COMMERCIAL OFFICER | 3.831K | $28.36 | -$45.89K | SELL-OPTIONS | ∞ | 3.831K | Jun 28 - Jun 30 | View |
| Apr 05, 2023 | David Schenkein | DIRECTOR | 0 | $15.95 | -$225.81K | SELL-OPTIONS | 0.00% | 196.961K | Apr 03 | View |
| Mar 29, 2023 | David Schenkein | DIRECTOR | 0 | $15.60 | -$262.00K | SELL-OPTIONS | 0.00% | 196.961K | Mar 27 | View |
| Mar 15, 2023 | David Schenkein | DIRECTOR | 0 | $15.77 | -$268.82K | SELL-OPTIONS | 0.00% | 196.961K | Mar 13 | View |
| Mar 07, 2023 | Theodore James Jr Washburn | PRINCIPAL ACCOUNTING OFFICER | -504 | $24.29 | -$12.24K | SELL | -15.53% | 2.741K | Mar 03 | View |
| Mar 01, 2023 | David Schenkein | DIRECTOR | 0 | $17.21 | -$326.40K | SELL-OPTIONS | 0.00% | 196.961K | Feb 27 | View |
| Feb 21, 2023 | Theodore James Jr Washburn | PRINCIPAL ACCOUNTING OFFICER | -233 | $27.21 | -$6.34K | SELL | -8.03% | 2.668K | Feb 16 | View |
| Feb 16, 2023 | Theodore James Jr Washburn | PRINCIPAL ACCOUNTING OFFICER | -271 | $28.65 | -$18.08K | SELL | -8.54% | 2.901K | Feb 14 | View |
| Feb 15, 2023 | David Schenkein | DIRECTOR | 0 | $18.84 | -$391.40K | SELL-OPTIONS | 0.00% | 196.961K | Feb 13 | View |
| Feb 01, 2023 | David Schenkein | DIRECTOR | 0 | $19.19 | -$405.58K | SELL-OPTIONS | 0.00% | 196.961K | Jan 30 | View |
| Jan 19, 2023 | David Schenkein | DIRECTOR | 0 | $18.95 | -$396.09K | SELL-OPTIONS | 0.00% | 196.961K | Jan 17 | View |
| Mar 01, 2022 | Theodore James Jr Washburn | PRINCIPAL ACCOUNTING OFFICER | -108 | $30.00 | -$3.24K | SELL | -4.06% | 2.549K | Feb 25 | View |
| Feb 18, 2022 | Theodore James Jr Washburn | PRINCIPAL ACCOUNTING OFFICER | -233 | $30.81 | -$7.18K | SELL | -8.38% | 2.549K | Feb 16 | View |
| Feb 16, 2022 | Theodore James Jr Washburn | PRINCIPAL ACCOUNTING OFFICER | -271 | $31.10 | -$19.62K | SELL | -8.88% | 2.782K | Feb 14 | View |
| Jun 23, 2021 | Carman Alenson | PRINCIPAL ACCOUNTING OFFICER | 0 | $56.56 | -$17.95K | SELL-OPTIONS | 0.00% | 0 | Jun 21 | View |
| Jun 22, 2021 | Christopher Bowden | CHIEF MEDICAL OFFICER | 0 | $55.05 | -$490.86K | SELL-OPTIONS | 0.00% | 15.487K | Jun 18 | View |
| Jun 21, 2021 | Christopher Bowden | CHIEF MEDICAL OFFICER | 0 | $49.89 | -$50.69K | SELL-OPTIONS | 0.00% | 15.487K | Jun 17 | View |
| Jun 11, 2021 | Christopher Bowden | CHIEF MEDICAL OFFICER | 0 | $49.92 | -$569.19K | SELL-OPTIONS | 0.00% | 15.487K | Jun 09 - Jun 10 | View |
| Jun 09, 2021 | Christopher Bowden | CHIEF MEDICAL OFFICER | 0 | $49.91 | -$222.08K | SELL-OPTIONS | 0.00% | 15.487K | Jun 07 - Jun 08 | View |
| May 18, 2021 | Darrin Miles | CHIEF COMMERCIAL OFFICER | -3.462K | $55.41 | -$191.83K | SELL | -32.44% | 7.209K | May 14 | View |
| Apr 21, 2021 | Christopher Bowden | CHIEF MEDICAL OFFICER | 0 | $45.38 | -$342.75K | SELL-OPTIONS | 0.00% | 15.487K | Apr 19 - Apr 20 | View |
| Apr 20, 2021 | Carman Alenson | PRINCIPAL ACCOUNTING OFFICER | -1.118K | $55.89 | -$62.49K | SELL | -100.00% | 0 | Apr 16 | View |
| Apr 16, 2021 | Carman Alenson | PRINCIPAL ACCOUNTING OFFICER | -991 | $54.00 | -$53.51K | SELL | -46.99% | 1.118K | Apr 15 | View |
| Mar 16, 2021 | Darrin Miles | CHIEF COMMERCIAL OFFICER | -2.7K | $48.10 | -$129.87K | SELL | -20.19% | 10.671K | Mar 01 - Mar 05 | View |
| Sep 04, 2020 | Carman Alenson | — | -250 | $39.93 | -$9.98K | SELL | -57.60% | 184 | Sep 02 | View |
| May 21, 2020 | Christopher Bowden | — | 0 | $42.59 | -$53.22K | OPTION EXERCISE | 0.00% | 8.306K | May 20 | View |
| Mar 04, 2020 | Carman Alenson | — | -345 | $47.30 | -$16.32K | SELL | -65.22% | 184 | Mar 02 | View |
| Feb 28, 2020 | Carman Alenson | — | -472 | $47.12 | -$22.24K | SELL | -71.95% | 184 | Feb 26 | View |
| Feb 24, 2020 | Carman Alenson | — | -2.427K | $53.37 | -$129.53K | SELL | -92.95% | 184 | Feb 20 | View |
| Feb 18, 2020 | Christopher Bowden | — | 0 | $42.66 | -$106.48K | OPTION EXERCISE | 0.00% | 1.65K | Feb 13 | View |
| Feb 13, 2020 | Christopher Bowden | — | 0 | $42.59 | -$9.23K | OPTION EXERCISE | 0.00% | 1.65K | Feb 11 | View |
| Feb 06, 2020 | Christopher Bowden | — | -5.665K | $42.62 | -$939.90K | OPTION EXERCISE | -77.44% | 1.65K | Feb 04 - Feb 05 | View |
| Dec 30, 2019 | Carman Alenson | PRINCIPAL ACCOUNTING OFFICER | -2.95K | $50.09 | -$147.77K | SELL | -94.13% | 184 | Dec 26 | View |
| Nov 15, 2019 | Jacqualyn Fouse | CHIEF EXECUTIVE OFFICER | 40.322K | $31.00 | $1.25M | BUY | 2880.14% | 41.722K | Nov 13 | View |
| Nov 15, 2019 | David Schenkein | DIRECTOR | 8.064K | $31.00 | $249.98K | BUY | 4.78% | 176.649K | Nov 13 | View |
| Nov 14, 2019 | CELGENE CORP DECelgene European Investment Co LLCCelgene Switzerland LLCCelgene Alpine Investment Co LLC | 10% OWNER | 403.225K | $31.00 | $12.50M | BUY | 19.36% | 2.486157M | Nov 12 | View |
FAQ
Is insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.